Abstract

Many patients with plasma cell disorders suffer from peripheral neuropathy, but differential diagnosis with chronic inflammatory demyelinating polyneuropathy (CIDP) is difficult. We aimed to (1) identify factors useful for differential diagnosis between peripheral neuropathy associated with plasma cell disorders versus CIDP and (2) determine whether neuropathy presentations and severity varied across the spectrum of different plasma cell disorders. A retrospective chart review of 18 monoclonal gammopathy of unknown significance (MGUS) patients, 15 POEMS syndrome patients and 34 CIDP patients between January 2005 and December 2016 was conducted. The peripheral neuropathy associated with plasma cell disorders seemed to be more sensory oriented compared to CIDP. MGUS patients were significantly older than CIDP patients (median age 70 vs. 59, respectively, p = 0.027). POEMS syndrome patients showed significantly higher platelet count at the time of neuropathy presentation compared to CIDP (p = 0.028). Lambda type MGUS patients were associated with less severe symptoms compared to POEMS syndrome patients despite harboring lambda monoclonal gammopathy as a common denominator. Kappa type MGUS patients showed predominantly axonal type neuropathy compared to its counterpart and POEMS syndrome. Careful inspection of clinical profiles and symptoms of patients presenting with neuropathy can help to discriminate those with underlying plasma cell disorders. The phenotype of neuropathy, platelet count and age at presentation seem to be the most useful indicators.

Highlights

  • Many patients with plasma cell disorders suffer from peripheral neuropathy, but differential diagnosis with chronic inflammatory demyelinating polyneuropathy (CIDP) is difficult

  • Plasma cell disorders ranges from subclinical monoclonal gammopathy of unknown significance (MGUS) to malignant systemic disorders such as multiple myeloma and amyloidosis, and POEMS syndrome

  • It appears that 85% to 100% of the patients with POEMS syndrome or osteosclerotic variant of multiple myeloma have neuropathy at disease diagnosis4,5, while approximately a third of the patients with MGUS suffer from neuropathy6–8

Read more

Summary

Introduction

Many patients with plasma cell disorders suffer from peripheral neuropathy, but differential diagnosis with chronic inflammatory demyelinating polyneuropathy (CIDP) is difficult. Neuropathy is the sole initial symptoms for many patients, underdiagnosis (i.e not testing for the presence of monoclonal gammopathy) or confusion with chronic inflammatory demyelinating polyneuropathy (CIDP) often occur, subsequently leading to inappropriate management. To this end, we selected MGUS patients with neuropathy, POEMS syndrome patients and CIDP patients and compared their clinical characteristics and course to [1] identify factors useful for differential diagnosis between peripheral neuropathy associated with plasma cell. Disorders versus CIDP and [2] determine whether neuropathy presentations and severity varied across the spectrum of different plasma cell disorders

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call